Insiderhandel: SVP and CMO verkauft Aktien von Dynavax Technologies im Wert von 9.012$
Janssen, Robert - Vorstand - Tag der Transaktion: 2023-08-24...…
10,463€
0,43%
Echtzeit-Aktienkurs Dynavax Technologies Corp.
Bid:
Ask:
Nachrichten zur Dynavax Technologies Corp. Aktie
Insiderhandel: SVP and CMO verkauft Aktien von Dynavax Technologies im Wert von 523.204$
Janssen, Robert - Vorstand - Tag der Transaktion: 2023-08-23...…
Wall Street Analysts See a 70.61% Upside in Dynavax Technologies (DVAX): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 70.6% in Dynavax Technologies (DVAX).…
Insiderhandel: SVP and CMO verkauft Aktien von Dynavax Technologies im Wert von 39.130$
Janssen, Robert - Vorstand - Tag der Transaktion: 2023-08-08...…
Dynavax Technologies (DVAX) Q2 2023 Earnings Call Transcript
DVAX earnings call for the period ending June 30, 2023....…
Dynavax Technologies (DVAX) Q2 Earnings and Revenues Surpass Estimates
Dynavax Technologies (DVAX) delivered earnings and revenue surprises of 133.33% and 18.08%, respectively, for the quarter ended June 2023. Do…
Dynavax GAAP EPS of $0.03 beats by $0.12, revenue of $60.25M beats by $11.87M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Dynavax Reports Second Quarter 2023 Financial Results and Raises Full Year Revenue Guidance
Generated record quarterly HEPLISAV-B® vaccine net product revenue of $56 million, a 73% year-over-year increase Full year HEPLISAV-B net product…
Wall Street Analysts Think Dynavax Technologies (DVAX) Could Surge 80.16%: Read This Before Placing a Bet
The consensus price target hints at an 80.2% upside potential for Dynavax Technologies (DVAX). While empirical research shows that this…
Dynavax Technologies (DVAX) Soars 5.6%: Is Further Upside Left in the Stock?
Dynavax Technologies (DVAX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions…
Form 8-K DYNAVAX TECHNOLOGIES For: May 26
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Dynavax to Present at the JMP Securities Life Sciences Conference
EMERYVILLE, Calif., May 8, 2023 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative…
Insiderhandel: President & COO verkauft Aktien von Dynavax Technologies im Wert von 190.914$
Novack, David F. - Vorstand - Tag der Transaktion: 2023-05-04...…
The Latest Analyst Ratings for Dynavax Technologies
Latest Ratings for DVAX
DateFirmActionFromTo Dec 2021HC Wainwright & Co.MaintainsBuy Aug 2021HC Wainwright & Co.MaintainsBuy Aug 2021Goldman SachsInitiates Coverage…
Dynavax Technologies (DVAX) Q1 2023 Earnings Call Transcript
DVAX earnings call for the period ending March 31, 2023....…
Dynavax misses on bottom line, but reaffirms 2023 guidance
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Dynavax Reports First Quarter 2023 Financial Results
HEPLISAV-B® vaccine net product revenue increased 109% year-over-year to $43.5 million in the first quarter of 2023 Reaffirming HEPLISAV-B net…
Dynavax to Report First Quarter 2023 Financial Results and Host Conference Call on May 2, 2023
EMERYVILLE, Calif., April 18, 2023 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing…
Dynavax Technologies (DVAX) Q4 2022 Earnings Call Transcript
DVAX earnings call for the period ending December 31, 2022....…
Dynavax Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Financial Guidance
2022 total revenue of $723 million, up 64% from $439 million in 2021 HEPLISAV-B® vaccine net product revenue of $126…
Form 8-K DYNAVAX TECHNOLOGIES For: Feb 23
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Dynavax GAAP EPS of $0.45 in-line, revenue of $184.49M beats by $6.11M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Dynavax announces uplisting to the Nasdaq global select market
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Dynavax Announces Uplisting to the Nasdaq Global Select Market
EMERYVILLE, Calif., Jan. 31, 2023 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company focused on developing…
Global Hepatitis B Virus (HBV) Vaccine Market Report 2023-2027 Featuring GSK, Merck, Sanofi, Dynavax, LG Chem, VBI Vaccines and Meiji Group Among Others
DUBLIN, Jan. 31, 2023 /PRNewswire/ -- The "Global Hepatitis B Virus (HBV) Vaccine Market: Analysis By End User (Adult &…
Form 8-K DYNAVAX TECHNOLOGIES For: Jan 09
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Implied Volatility Surging for Dynavax Technologies (DVAX) Stock Options
Investors need to pay close attention to Dynavax Technologies (DVAX) stock based on the movements in the options market lately....…
Dynavax Adjuvant Based COVID-19 Vaccine Lowers The Risk Of Transmission
read more...…
Clover, Dynavax COVID vaccine helps reduce household transmission of virus in trial
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: President & COO verkauft Aktien von Dynavax Technologies im Wert von 650.984$
Novack, David F. - Vorstand - Tag der Transaktion: 2022-11-08...…
Surging Earnings Estimates Signal Upside for Dynavax Technologies (DVAX) Stock
Dynavax Technologies (DVAX) shares have started gaining and might continue moving higher in the near term, as indicated by solid…
Wall Street Analysts See a 154% Upside in Dynavax Technologies (DVAX): Can the Stock Really Move This High?
The consensus price target hints at a 154.4% upside potential for Dynavax Technologies (DVAX). While empirical research shows that this…
Dynavax Technologies (DVAX) Q3 2022 Earnings Call Transcript
DVAX earnings call for the period ending September 30, 2022....…
Dynavax Technologies (DVAX) Beats Q3 Earnings and Revenue Estimates
Dynavax Technologies (DVAX) delivered earnings and revenue surprises of 30.30% and 11.83%, respectively, for the quarter ended September 2022. Do…
Dynavax Technologies (DVAX) Recently Broke Out Above the 50-Day Moving Average
Good things could be on the horizon when a stock surpasses the 50-Day simple moving average. How should investors react?...…
Does Dynavax Technologies (DVAX) Have the Potential to Rally 210% as Wall Street Analysts Expect?
The mean of analysts price targets for Dynavax Technologies (DVAX) points to a 210.1% upside in the stock. While this…
Dynavax to Present at the H.C. Wainwright 3rd Annual Hepatitis B Virus Virtual Conference
EMERYVILLE, Calif., Oct. 14, 2022 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative…
Are Investors Undervaluing Dynavax Technologies (DVAX) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to…